• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与DNA损伤修复分子亚型相关的五基因特征可预测肝细胞癌的总生存期。

A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma.

作者信息

Huo Junyu, Fan Xinyi, Qi Bingxin, Sun Peng

机构信息

Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.

Department of Allergy, The Affiliated Hospital of Qingdao University, Qingdao, China.

出版信息

Front Genet. 2022 Jan 20;13:771819. doi: 10.3389/fgene.2022.771819. eCollection 2022.

DOI:10.3389/fgene.2022.771819
PMID:35126478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8811360/
Abstract

DNA damage repair (DDR) is an important mechanism for the occurrence and development of hepatocellular carcinoma (HCC), but its impact on prognosis has not been fully understood. A total of 904 HCC patients were included in our study, TCGA ( = 370) and GSE14520 ( = 239) were merged into a large-sample training cohort ( = 609). The training cohort was clustered into C1 and C2 based on prognostic DDR-related genes, the differentially expressed genes (DEGs) between C1 and C2 were identified by the Wilcoxon signed-rank test referred to criteria (|log2FC|≥1 and FDR< 0.05). The univariate Cox analysis was used to screen the prognostic-related DEGs, and Lasso penalized Cox regression analysis was used to construct the risk score. The patients were clarified into high- and low-risk groups based on the median risk score. ICGC ( = 231) and GSE116174 ( = 64) cohorts were used for external validation of the risk score's prognostic value. The Kaplan-Meier survival analysis showed that the high-risk group had a significantly reduced overall survival (OS) compared to the low-risk group in the three independent cohorts, and the time-dependent ROC curve showed that the five-gene (STMN1, PON1, PLOD2, MARCKSL1, and SPP1) risk score with a high accuracy in predicting OS. The patients with AFP >300 ng/ml, tumor poor differentiation (grade 3-4), micro and macro vascular tumor invasion, advanced stage (AJCC III-IV, BCLC stage B-C, and CLIP score >2) exhibited a higher risk score. Subgroup survival analysis found that the risk score was applicable to patients with different clinical characteristics. GO and KEGG functional enrichment analysis revealed that cell cycle, p53 signaling, TNF signaling-related pathways were upregulated in the high-risk group. The higher infiltration level of activated CD4 T cell, CD56 bright natural killer cell, plasmacytoid dendritic cell, and type 2 T helper cells were found to lead an unfavorable impact on the OS of HCC patients, and these four kinds of immune cells exhibited a higher infiltration level in the high-risk group. The five-gene risk score proposed in the research may provide new insights into the individualized evaluation of HCC prognosis.

摘要

DNA损伤修复(DDR)是肝细胞癌(HCC)发生发展的重要机制,但其对预后的影响尚未完全明确。本研究共纳入904例HCC患者,将TCGA队列(n = 370)和GSE14520队列(n = 239)合并为一个大样本训练队列(n = 609)。基于预后相关的DDR基因将训练队列分为C1和C2两组,采用Wilcoxon符号秩检验(标准为|log2FC|≥1且FDR<0.05)确定C1和C2之间的差异表达基因(DEG)。采用单因素Cox分析筛选与预后相关的DEG,并使用Lasso惩罚Cox回归分析构建风险评分。根据中位风险评分将患者分为高风险组和低风险组。使用ICGC队列(n = 231)和GSE116174队列(n = 64)对风险评分的预后价值进行外部验证。Kaplan-Meier生存分析显示,在三个独立队列中,高风险组的总生存期(OS)明显低于低风险组,且时间依赖性ROC曲线显示,五基因(STMN1、PON1、PLOD2、MARCKSL1和SPP1)风险评分在预测OS方面具有较高的准确性。甲胎蛋白(AFP)>300 ng/ml、肿瘤低分化(3-4级)、微血管和大血管侵犯、晚期(美国癌症联合委员会III-IV期、巴塞罗那临床肝癌分期B-C期和意大利肝癌协作组评分>2)的患者风险评分较高。亚组生存分析发现,风险评分适用于不同临床特征的患者。基因本体(GO)和京都基因与基因组百科全书(KEGG)功能富集分析显示,高风险组中细胞周期、p53信号传导、肿瘤坏死因子(TNF)信号传导相关通路上调。研究发现,活化的CD4 T细胞、CD56 bright自然杀伤细胞、浆细胞样树突状细胞和2型辅助性T细胞的浸润水平较高对HCC患者的OS产生不利影响,且这四种免疫细胞在高风险组中的浸润水平较高。本研究提出的五基因风险评分可能为HCC预后的个体化评估提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/11681710898e/fgene-13-771819-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/4cc04b9a81ab/fgene-13-771819-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/62c92e778a09/fgene-13-771819-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/d23b9da631c1/fgene-13-771819-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/57b782f598d6/fgene-13-771819-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/43e952d3718e/fgene-13-771819-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/9214bf41061a/fgene-13-771819-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/ca57065e2ee0/fgene-13-771819-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/d2bc346d8416/fgene-13-771819-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/11681710898e/fgene-13-771819-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/4cc04b9a81ab/fgene-13-771819-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/62c92e778a09/fgene-13-771819-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/d23b9da631c1/fgene-13-771819-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/57b782f598d6/fgene-13-771819-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/43e952d3718e/fgene-13-771819-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/9214bf41061a/fgene-13-771819-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/ca57065e2ee0/fgene-13-771819-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/d2bc346d8416/fgene-13-771819-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea3/8811360/11681710898e/fgene-13-771819-g009.jpg

相似文献

1
A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma.一种与DNA损伤修复分子亚型相关的五基因特征可预测肝细胞癌的总生存期。
Front Genet. 2022 Jan 20;13:771819. doi: 10.3389/fgene.2022.771819. eCollection 2022.
2
A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma.一种适用于肝细胞癌预后及免疫微环境评估的铁死亡和焦亡分子亚型相关特征
Front Cell Dev Biol. 2021 Nov 15;9:761839. doi: 10.3389/fcell.2021.761839. eCollection 2021.
3
DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer.基于DNA损伤修复分子亚型的免疫特征可用于结肠癌的预后评估及免疫治疗反应预测。
Transl Cancer Res. 2023 Oct 31;12(10):2781-2805. doi: 10.21037/tcr-23-747. Epub 2023 Oct 17.
4
Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma.综合分析源于肝细胞癌的代谢途径活性亚型的预后特征。
Cancer Med. 2023 Jan;12(1):898-912. doi: 10.1002/cam4.4858. Epub 2022 Jun 1.
5
Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma.用于肝细胞癌预后分层分析的DNA损伤反应与修复相关基因对特征的鉴定
Front Pharmacol. 2022 Apr 5;13:857060. doi: 10.3389/fphar.2022.857060. eCollection 2022.
6
A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma.一种用于预测肝细胞癌预后的强大的十二基因特征。
Cancer Cell Int. 2020 Jun 3;20:207. doi: 10.1186/s12935-020-01294-9. eCollection 2020.
7
A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma.一种与肝细胞癌肿瘤突变负荷相关的15个免疫相关基因对的预后模型。
Front Mol Biosci. 2020 Nov 13;7:581354. doi: 10.3389/fmolb.2020.581354. eCollection 2020.
8
A programmed cell death-related gene signature to predict prognosis and therapeutic responses in liver hepatocellular carcinoma.一种用于预测肝细胞癌预后和治疗反应的程序性细胞死亡相关基因特征
Discov Oncol. 2024 Mar 11;15(1):71. doi: 10.1007/s12672-024-00924-2.
9
Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma.肝细胞癌患者预后相关免疫基因的鉴定、验证及通路富集分析
Front Oncol. 2021 Sep 20;11:695001. doi: 10.3389/fonc.2021.695001. eCollection 2021.
10
Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.鉴定和描述一个 25-lncRNA 预后标志物用于预测肝细胞癌早期复发。
BMC Cancer. 2021 Oct 30;21(1):1165. doi: 10.1186/s12885-021-08827-z.

引用本文的文献

1
Machine learning-based identification of diagnostic and prognostic mitotic cell cycle genes in hepatocellular carcinoma.基于机器学习的肝细胞癌诊断和预后有丝分裂细胞周期基因鉴定
PLoS One. 2025 Aug 28;20(8):e0331118. doi: 10.1371/journal.pone.0331118. eCollection 2025.
2
Identification of two heterogeneous subtypes of hepatocellular carcinoma with distinct pathway activities and clinical outcomes based on gene set variation analysis.基于基因集变异分析鉴定出具有不同通路活性和临床结局的两种肝细胞癌异质性亚型。
Front Genet. 2024 Sep 10;15:1441189. doi: 10.3389/fgene.2024.1441189. eCollection 2024.
3
DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma.

本文引用的文献

1
A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma.一种适用于肝细胞癌预后及免疫微环境评估的铁死亡和焦亡分子亚型相关特征
Front Cell Dev Biol. 2021 Nov 15;9:761839. doi: 10.3389/fcell.2021.761839. eCollection 2021.
2
Construction and Validation of a Universal Applicable Prognostic Signature for Gastric Cancer Based on Seven Immune-Related Gene Correlated With Tumor Associated Macrophages.基于与肿瘤相关巨噬细胞相关的七个免疫相关基因构建并验证胃癌通用预后特征
Front Oncol. 2021 Jun 11;11:635324. doi: 10.3389/fonc.2021.635324. eCollection 2021.
3
DNA 损伤修复相关基因特征可用于识别肝癌的免疫状态并预测其预后。
Sci Rep. 2023 Nov 3;13(1):18978. doi: 10.1038/s41598-023-45999-z.
4
Identification of Cuproptosis-Related Subtypes, Establishment of a Prognostic Signature and Characterization of the Tumor Microenvironment in Gastric Cancer.胃癌中铜死亡相关亚型的鉴定、预后特征的建立及肿瘤微环境的表征
Int J Gen Med. 2023 May 2;16:1631-1652. doi: 10.2147/IJGM.S404847. eCollection 2023.
5
Identification and verification of the prognostic value of CUL7 in colon adenocarcinoma.鉴定和验证 CUL7 在结肠腺癌中的预后价值。
Front Immunol. 2022 Oct 11;13:1043512. doi: 10.3389/fimmu.2022.1043512. eCollection 2022.
Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma.
基于TP53改变的可靠六基因预后特征用于肝细胞癌的构建与验证
Front Oncol. 2021 Jun 10;11:618976. doi: 10.3389/fonc.2021.618976. eCollection 2021.
4
Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer.开发和验证稳健的胃癌免疫相关预后标志物。
J Immunol Res. 2021 Apr 30;2021:5554342. doi: 10.1155/2021/5554342. eCollection 2021.
5
Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma.肝细胞癌代谢相关预后模型的建立与验证
J Clin Transl Hepatol. 2021 Apr 28;9(2):169-179. doi: 10.14218/JCTH.2020.00114. Epub 2021 Feb 22.
6
Eight-gene prognostic signature associated with hypoxia and ferroptosis for gastric cancer with general applicability.与缺氧和铁死亡相关的适用于胃癌的 8 基因预后签名。
Epigenomics. 2021 Jun;13(11):875-890. doi: 10.2217/epi-2020-0411. Epub 2021 May 4.
7
Eleven immune-gene pairs signature associated with TP53 predicting the overall survival of gastric cancer: a retrospective analysis of large sample and multicenter from public database.11 个与 TP53 相关的免疫基因对预测胃癌总生存期的标志:来自公共数据库的大样本和多中心回顾性分析。
J Transl Med. 2021 Apr 29;19(1):183. doi: 10.1186/s12967-021-02846-x.
8
Analysis of Serum Paraoxonase 1 Using Mass Spectrometry and Lectin Immunoassay in Patients With Alpha-Fetoprotein Negative Hepatocellular Carcinoma.采用质谱法和凝集素免疫分析法对甲胎蛋白阴性肝细胞癌患者血清对氧磷酶1的分析
Front Oncol. 2021 Apr 6;11:651421. doi: 10.3389/fonc.2021.651421. eCollection 2021.
9
The role of DNA damage and repair in liver cancer.DNA 损伤与修复在肝癌中的作用。
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188493. doi: 10.1016/j.bbcan.2020.188493. Epub 2020 Dec 13.
10
Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma.开发和验证与 CTNNB1 相关的用于肝细胞癌的代谢预后模型。
J Cell Mol Med. 2021 Jan;25(2):1151-1165. doi: 10.1111/jcmm.16181. Epub 2020 Dec 9.